Peptides are fast becoming one of the most talked-about topics. We receive questions about them daily, so we have put together a blog post with some useful information.
This blog post breaks down what peptides are, why they’ve become such a prominent topic, the current regulatory position in the UK, how the supply chain works, and the key next steps to consider.
What are Peptides?
Peptides are short chains of amino acids that act as signalling molecules in the body. Rather than simply blocking a biological pathway like many conventional drugs, they work by modulating physiological processes.
In fact, you may already be familiar with one class of peptides without realising it. GLP-1 receptor agonists, now widely prescribed for weight management and type 2 diabetes, are themselves peptides.
Why is everyone talking about peptides now?
The US has recently reversed restrictions on several peptide compounds, and interest has surged globally. Compounds like BPC-157, widely used in the US for inflammation and tissue healing, are generating significant attention. The science is genuinely compelling, and clinicians are increasingly being asked about them.
But here's the problem: interest has outpaced regulation.
Are peptides legal in the UK?
In the UK, peptides such as BPC-157 are not able to be sold for use in humans. At Roseway Labs, we are asked regularly to supply peptides, and our position is clear.
The MHRA will not permit them for human use because the active ingredients are not manufactured at sites regulated by a recognised authority such as the MHRA or FDA. Ingredients that are not approved for human use cannot be present in facilities that make human medication.
Roseway Labs have engaged with multiple manufacturers globally, and the answer is consistently the same; no suitable certifications exist.
Without that regulatory infrastructure, these ingredients cannot and should not move through legitimate pharmaceutical channels. What fills the void instead is a grey market, where products are labelled "for research use only," sold with unknown purity, and consumed with no clinical oversight.
We have seen this pattern before. It looks very much like the early steroid market.
The real risk isn't the science - it's the supply chain
The molecules themselves are worth taking seriously. The issue is the absence of the infrastructure needed to use them safely:
- No approved baseline laboratory testing
- No interval monitoring
- No adverse event tracking
- No way to verify what is actually in the vial
For patients, this matters enormously. Purchasing peptides through grey market channels means you have no assurance of purity, dosage accuracy, or safety. Any UK clinician prescribing these compounds outside of a regulated framework is also taking on significant personal and professional risk.
What should you do if you're curious about peptides?
The science is worth exploring, but the black market is not the appropriate route.
If you are interested in peptides as part of your health optimisation journey, we recommend you wait until regulations for peptides in the UK are introduced. Later in 2026, twelve peptides may become FDA approved for human use. If this happens, it will be a gamechanger.
We will continue to monitor developments closely as the regulatory landscape evolves. Our commitment, as always, is to personalised medicine that is both innovative and safe. We care about protecting our team and our patients’ health. When compliant, regulated peptide options become available, we will be quick to offer them.
Until then, please do speak to your clinician if you have questions. You can also get in touch with the Roseway Labs team at info@rosewaylabs.com.